Taken together, this study demonstrates a novel anti-cancer mechanism for CIL-102 to inhibit cell migration and the invasiveness of colorectal cancer cells via the upregulation of ERP29 and FUMH. This evidence concerns the gene ERP29 and colorectal cancer.